Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Q4 2021 Results Conference Call February 9, 2022 8:00 AM ET Company Participants Ran Meir - SVP, Head IR KÃ¥re Schultz - CEO Eli Kalif - CFO Sven Dethlefs - Head, North America Commercial Conference Call Participants Umer Raffat - Evercore Ronny Gal - Bernstein Elliot Wilbur - Raymond James Navann Ty - Citi Chris Schott - JP Morgan Gary Nachman - BMO Capital Markets Jason Gerberry - Bank of America Operator Good day. And thank you for standing by. And welcome ...

| --- | --- | |-------------------------------------|-------| | | | | | | | | | | | | | | | | Teva Pharmaceutical Industries Ltd. | | | J.P. Morgan Healthcare Conference | | | Kåre Schultz | | | President & CEO | | | January 11, 2022 | | | | | Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations and are subject to s ...